Bosentan for patients with chronic thromboembolic pulmonary hypertension.

  title={Bosentan for patients with chronic thromboembolic pulmonary hypertension.},
  author={Fabio Giuseppe Vassallo and Metka Kodric and Cleante Scarduelli and Sergio Harari and Alfredo Potena and Angelo Scarda and Marco Piattella and Roberto Cassandro and Marco Confalonieri},
  journal={European journal of internal medicine},
  volume={20 1},
BACKGROUND Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease leading to worsening functional status and reduced survival for those patients who cannot undergo pulmonary endarterectomy (PEA). Pharmacotherapy with novel drugs for pulmonary hypertension may be useful in treating patients who are poor candidates for surgery, but there are still few clinical data on medical therapy for CTEPH. The aim of this prospective open-label, multicenter, study is to compare the… CONTINUE READING
4 Citations
25 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 25 references

Long term follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151–8

  • M Riedel, V Stanek, J Widinsky, I. Prerovsky
  • European Journal of Internal Medicine
  • 2009
Highly Influential
3 Excerpts

PankauH,Winkler J,WirtzH.Long-term bosentan in chronic thromboembolic pulmonary hypertension

  • SeyfarthHJ, S Hummerschmidt
  • Respiration
  • 2007

Similar Papers

Loading similar papers…